Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12831) 12831
Newspaper Article (240) 240
Book Chapter (234) 234
Newsletter (139) 139
Magazine Article (118) 118
Book / eBook (10) 10
Dissertation (8) 8
Publication (7) 7
Trade Publication Article (4) 4
Reference (3) 3
Web Resource (3) 3
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10647) 10647
male (6167) 6167
science & technology (6153) 6153
life sciences & biomedicine (5995) 5995
endocarditis (4928) 4928
female (4836) 4836
endocarditis, bacterial - drug therapy (4044) 4044
middle aged (3974) 3974
adult (3934) 3934
anti-bacterial agents - therapeutic use (3482) 3482
infectious diseases (2904) 2904
endocarditis, bacterial - microbiology (2876) 2876
aged (2857) 2857
biological and medical sciences (2718) 2718
medical sciences (2676) 2676
abridged index medicus (2193) 2193
endocarditis, bacterial - diagnosis (2178) 2178
endocarditis, bacterial - complications (1754) 1754
endocarditis, bacterial - etiology (1731) 1731
cardiovascular system & cardiology (1666) 1666
microbiology (1614) 1614
infective endocarditis (1592) 1592
cardiac & cardiovascular systems (1549) 1549
antibiotics (1509) 1509
treatment outcome (1336) 1336
staphylococcal infections - drug therapy (1317) 1317
bacterial diseases (1269) 1269
endocarditis, bacterial - therapy (1217) 1217
adolescent (1194) 1194
heart (1170) 1170
risk factors (1162) 1162
human bacterial diseases (1145) 1145
echocardiography (1120) 1120
endocarditis, bacterial - surgery (1093) 1093
infections (1083) 1083
animals (1060) 1060
surgery (1046) 1046
general & internal medicine (1007) 1007
medicine, general & internal (905) 905
child (886) 886
retrospective studies (867) 867
health aspects (831) 831
heart valve prosthesis (826) 826
microbial sensitivity tests (820) 820
mortality (780) 780
cardiology. vascular system (779) 779
bacterial endocarditis, myocarditis and pericarditis. bacterial diseases of the aorta, limb vessels and lymphatic vessels (765) 765
care and treatment (738) 738
aged, 80 and over (733) 733
patients (725) 725
streptococcal infections - drug therapy (720) 720
staphylococcus aureus (710) 710
pharmacology. drug treatments (687) 687
prognosis (675) 675
diagnosis (670) 670
endocarditis, bacterial - diagnostic imaging (670) 670
endocardial and cardiac valvular diseases (664) 664
staphylococcal infections - microbiology (664) 664
anti-bacterial agents - administration & dosage (660) 660
diagnosis, differential (658) 658
pharmacology & pharmacy (642) 642
echocardiography, transesophageal (641) 641
heart valve prosthesis - adverse effects (641) 641
drug therapy, combination (622) 622
antibiotics. antiinfectious agents. antiparasitic agents (612) 612
bacteria (596) 596
immunology (591) 591
time factors (581) 581
follow-up studies (577) 577
blood (572) 572
endocarditis, bacterial (569) 569
endocarditis, bacterial - mortality (555) 555
antibacterial agents (547) 547
staphylococcal infections - diagnosis (540) 540
endocarditis, bacterial - prevention & control (539) 539
endocarditis, bacterial - epidemiology (537) 537
research article (537) 537
penicillins - therapeutic use (535) 535
old medline (514) 514
bacteremia (512) 512
research (497) 497
endocarditis - drug therapy (490) 490
anti-bacterial agents - pharmacology (480) 480
child, preschool (480) 480
endocarditis - microbiology (480) 480
case report (478) 478
gentamicins - therapeutic use (475) 475
staphylococcal infections - complications (464) 464
rabbits (450) 450
vancomycin - therapeutic use (448) 448
aortic valve - surgery (444) 444
medicine & public health (444) 444
internal medicine (443) 443
endocarditis - diagnosis (435) 435
medicine (433) 433
drug therapy (428) 428
staphylococcus infections (427) 427
aortic valve (419) 419
cardiology (415) 415
bacteremia - microbiology (403) 403
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11853) 11853
French (544) 544
Spanish (345) 345
German (326) 326
Japanese (209) 209
Russian (156) 156
Italian (143) 143
Portuguese (88) 88
Polish (79) 79
Danish (32) 32
Turkish (29) 29
Chinese (28) 28
Norwegian (27) 27
Dutch (26) 26
Czech (22) 22
Romanian (20) 20
Swedish (16) 16
Hebrew (13) 13
Hungarian (9) 9
Finnish (8) 8
Croatian (7) 7
Korean (6) 6
Slovak (6) 6
Serbian (5) 5
Ukrainian (5) 5
Bulgarian (4) 4
Afrikaans (1) 1
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
by Iversen, Kasper and Ihlemann, Nikolaj and Gill, Sabine U and Madsen, Trine and Elming, Hanne and Jensen, Kaare T and Bruun, Niels E and Høfsten, Dan E and Fursted, Kurt and Christensen, Jens J and Schultz, Martin and Klein, Christine F and Fosbøll, Emil L and Rosenvinge, Flemming and Schønheyder, Henrik C and Køber, Lars and Torp-Pedersen, Christian and Helweg-Larsen, Jannik and Tønder, Niels and Moser, Claus and Bundgaard, Henning
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 5, pp. 415 - 424
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Length of Stay | Endocarditis, Bacterial - drug therapy | Recurrence | Administration, Oral | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Bacteremia - drug therapy | Kaplan-Meier Estimate | Male | Administration, Intravenous | Heart Valve Prosthesis - microbiology | Anti-Bacterial Agents - pharmacokinetics | Intention to Treat Analysis | Endocarditis, Bacterial - microbiology | Female | Aged | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Infective endocarditis | Usage | Care and treatment | Antibiotics | Comparative analysis | Oral medication | Heart | Intravenous administration | Hospitals | Coagulase | Surgery | Endocarditis | Society | Cardiology | Patients | Bacteremia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Safety and Clinical Outcomes when Utilizing High-Dose (>=8 mg/kg) Daptomycin Therapy
by Moise, Pamela A and Hershberger, Ellie and Amodio-Groton, Maria I and Lamp, Kenneth C
The Annals of pharmacotherapy, ISSN 1060-0280, 07/2009, Volume 43, Issue 7, pp. 1211 - 1219
Gram-positive infections | Daptomycin | Higher doses | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Skin Diseases, Bacterial - microbiology | Humans | Middle Aged | Male | Skin Diseases, Bacterial - drug therapy | Bacteremia - microbiology | Dose-Response Relationship, Drug | Young Adult | Anti-Bacterial Agents - therapeutic use | Gram-Positive Bacterial Infections - microbiology | Endocarditis, Bacterial - microbiology | Adult | Female | Registries | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Daptomycin - adverse effects | Daptomycin - therapeutic use | Endocarditis, Bacterial - drug therapy | Bacteremia - drug therapy | Treatment Outcome | Adolescent | Aged | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii
by Bizzini, A and Entenza, J. M and Moreillon, P
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 04/2007, Volume 59, Issue 4, pp. 607 - 615
Antibiotics | Experimental endocarditis | Arginine deiminase | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cardiology. Vascular system | Heart | Endocardial and cardiac valvular diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Blotting, Southern | Genes, Bacterial - genetics | Rats, Wistar | Streptococcus - growth & development | Molecular Sequence Data | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Transformation, Bacterial | Base Sequence | Penicillin Resistance - genetics | Plasmids - genetics | Endocarditis, Bacterial - microbiology | Female | Carbon - metabolism | Endocarditis, Bacterial - drug therapy | Streptococcal Infections - microbiology | Penicillins - therapeutic use | Bacterial Proteins - genetics | Rats | Repressor Proteins - genetics | DNA Primers | DNA-Binding Proteins - genetics | Phenotype | Animals | DNA, Bacterial - genetics | Streptococcus - genetics | Streptococcal Infections - drug therapy | Penicillin | Mutation | Gene expression | Drug resistance | Carbon | Streptococcus infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Enterococcal Endocarditis in Sweden, 1995-1999: Can Shorter Therapy with Aminoglycosides Be Used?
by Lars Olaison and Kimmo Schadewitz and Swedish Soc Infect Dis Quality Ass and Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis and Sahlgrenska akademin and Institutionen för invärtesmedicin, Avdelningen för infektionssjukdomar and Göteborgs universitet and Gothenburg University and Institute of Internal Medicine, Dept of Infectious Diseases and Sahlgrenska Academy
Clinical infectious diseases, ISSN 1058-4838, 1/2002, Volume 34, Issue 2, pp. 159 - 166
Relapse | Antibiotics | University hospitals | Major Articles | Cell walls | Antimicrobials | Endocarditis | Penicillin | Aminoglycosides | Infections | Heart valves | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Bacterial endocarditis, myocarditis and pericarditis. Bacterial diseases of the aorta, limb vessels and lymphatic vessels | Enterococcus faecium - drug effects | Endocarditis, Bacterial - etiology | Enterococcus faecalis - drug effects | Prospective Studies | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Gram-Positive Bacterial Infections - mortality | Lactams | Male | Secondary Prevention | Streptococcal Infections - mortality | Enterococcus faecium - isolation & purification | Streptococcus - drug effects | Anti-Bacterial Agents - therapeutic use | Streptococcus - isolation & purification | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Gram-Positive Bacterial Infections - complications | Endocarditis, Bacterial - drug therapy | Endocarditis, Bacterial - diagnosis | Gram-Positive Bacterial Infections - diagnosis | Sweden - epidemiology | Enterococcus faecalis - isolation & purification | Streptococcal Infections - diagnosis | Heart Valve Prosthesis - microbiology | Adolescent | Streptococcal Infections - drug therapy | Aged | Streptococcal Infections - complications | Gram-Positive Bacterial Infections - drug therapy | Dosage and administration | Endocarditis, Bacterial | Drug therapy | Index Medicus | Enterococcus faecalis | Bacterial | 80 and over | epidemiology | Anti-Bacterial Agents | Sweden | Combination | Streptococcal Infections | complications | Heart Valve Prosthesis | Infektionsmedicin | Drug Therapy | microbiology | diagnosis | drug effects | etiology | Enterococcus faecium | Gram-Positive Bacterial Infections | Streptococcus | Infectious Medicine | mortality | therapeutic use | isolation & purification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Detection and characterization of bacterial polysaccharides in drug-resistant enterococci
by Ali, Liaqat and Blum, Hubert E and Sakιnç, Türkân
Glycoconjugate journal, ISSN 0282-0080, 10/2019, Volume 36, Issue 5, pp. 429 - 438
Life Sciences | Biochemistry, general | Pathology | Virulence | Capsular polysaccharide | E. faecium | Opsonophagocytosis | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Wall - immunology | Enterococcus faecium - drug effects | Humans | Drug Resistance, Bacterial | Teichoic Acids - chemistry | Lipopolysaccharides - immunology | Antibodies, Bacterial - biosynthesis | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Disease Models, Animal | Endocarditis, Bacterial - drug therapy | Antigens, Bacterial - chemistry | Leukocytes, Mononuclear - drug effects | Rats | Penicillin-Binding Proteins - pharmacology | Lipopolysaccharides - pharmacology | Leukocytes, Mononuclear - cytology | Anti-Bacterial Agents - pharmacology | Lipopolysaccharides - chemistry | Mice | Mice, Inbred BALB C | Lipopolysaccharides - isolation & purification | Gram-Positive Bacterial Infections - drug therapy | Bacterial Capsules - immunology | Enterococcus faecium - immunology | Rats, Wistar | Teichoic Acids - isolation & purification | Antigens, Bacterial - immunology | Antibodies, Bacterial - pharmacology | Penicillin-Binding Proteins - chemistry | Teichoic Acids - pharmacology | Leukocytes, Mononuclear - immunology | Endocarditis, Bacterial - microbiology | Female | Polysaccharides, Bacterial - isolation & purification | Polysaccharides, Bacterial - chemistry | Phagocytosis - drug effects | Polysaccharides, Bacterial - immunology | Antigens, Bacterial - isolation & purification | Teichoic Acids - immunology | Cell Wall - chemistry | Enterococcus faecium - chemistry | Urinary Tract Infections - drug therapy | Bacterial Capsules - chemistry | Animals | Penicillin-Binding Proteins - isolation & purification | Enterococcus faecium - pathogenicity | Penicillin-Binding Proteins - immunology | Opsonin Proteins - pharmacology | Primary Cell Culture | Viral antibodies | Antigens | Analysis | Endocarditis | Antibodies | Virulence (Microbiology) | Drug resistance | Microbial polysaccharides | Binding proteins | Organic acids | Protein binding | Health care | Capsular polysaccharides | Cell walls | Opsonization | Lipoteichoic acid | Infections | Urinary tract | Vaccines | Cell surface | Deletion mutant | Antibiotics | Clonal deletion | Penicillin | Bacteria | Urogenital system | Strains (organisms) | Saccharides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
by Fowler, Vance G and Boucher, Helen W and Corey, G. Ralph and Abrutyn, Elias and Karchmer, Adolf W and Rupp, Mark E and Levine, Donald P and Chambers, Henry F and Tally, Francis P and Vigliani, Gloria A and Cabell, Christopher H and Link, Arthur Stanley and DeMeyer, Ignace and Filler, Scott G and Zervos, Marcus and Cook, Paul and Parsonnet, Jeffrey and Bernstein, Jack M and Price, Connie Savor and Forrest, Graeme N and Fätkenheuer, Gerd and Gareca, Marcelo and Rehm, Susan J and Brodt, Hans Reinhardt and Tice, Alan and Cosgrove, Sara E and S aureus Endocarditis Bacteremia and S. aureus Endocarditis and Bacteremia Study Group
The New England journal of medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 7, pp. 653 - 665
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Bacterial diseases | Human bacterial diseases | Biological and medical sciences | Medical sciences | Bacterial sepsis | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Gentamicins - therapeutic use | Penicillins - therapeutic use | Humans | Middle Aged | Bacteremia - drug therapy | Male | Treatment Outcome | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Vancomycin - therapeutic use | Aged, 80 and over | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Daptomycin - therapeutic use | Drug therapy | Bacteremia | Endocarditis | Substance abuse treatment | Committees | Gram-positive bacteria | Staphylococcus infections | Drug dosages | Patients | Bacteriology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence
by Oechslin, Frank and Piccardi, Philippe and Mancini, Stefano and Gabard, Jérôme and Moreillon, Philippe and Entenza, José M and Resch, Gregory and Que, Yok-Ai
The Journal of infectious diseases, ISSN 0022-1899, 03/2017, Volume 215, Issue 5, pp. 703 - 712
Resistance | Pseudomonas aeruginosa | Antibiotic | Bacteriophage | Phage therapy | Endocarditis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Rats, Wistar | Endocarditis - therapy | Virulence | Pseudomonas Infections - therapy | Ciprofloxacin - pharmacology | Rats | Pseudomonas aeruginosa - drug effects | Microbial Sensitivity Tests | Animals | Endocarditis - microbiology | Pseudomonas aeruginosa - pathogenicity | Drug Resistance, Multiple, Bacterial | Female | Anti-Bacterial Agents - pharmacology | Phage Therapy - methods | Pseudomonas aeruginosa infections | Usage | Drug therapy | Risk factors | Index Medicus | Abridged Index Medicus | antibiotic | Major | phage therapy | endocarditis | bacteriophage | resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia
by Walraven, Carla J and North, Michael S and Marr-Lyon, Lisa and Deming, Paulina and Sakoulas, George and Mercier, Renée-Claude
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 10/2011, Volume 66, Issue 10, pp. 2386 - 2392
Pneumonia | Endocarditis | Mrsa | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cardiology. Vascular system | Heart | Endocardial and cardiac valvular diseases | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial sepsis | Antibiotics. Antiinfectious agents. Antiparasitic agents | Anti-Bacterial Agents - blood | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Bacteremia - mortality | Male | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Pneumonia, Bacterial - mortality | Treatment Failure | Vancomycin - pharmacology | Endocarditis, Bacterial - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Pneumonia, Bacterial - microbiology | Staphylococcal Infections - drug therapy | Hospital Mortality | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Vancomycin - blood | Bacterial Toxins - biosynthesis | Staphylococcal Infections - mortality | Exotoxins - biosynthesis | Vancomycin - therapeutic use | Leukocidins - biosynthesis | Pneumonia, Bacterial - drug therapy | Aged | Anti-Bacterial Agents - pharmacology | Staphylococcus infections | Drug resistance | Comparative analysis | Medical treatment | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Infective Endocarditis in Adults
by Mylonakis, Eleftherios and Calderwood, Stephen B
The New England journal of medicine, ISSN 0028-4793, 11/2001, Volume 345, Issue 18, pp. 1318 - 1330
Biological and medical sciences | Infectious diseases | Medical sciences | Bacterial diseases | Human bacterial diseases | Bacterial endocarditis, myocarditis and pericarditis. Bacterial diseases of the aorta, limb vessels and lymphatic vessels | Recurrence | Humans | Mycoses - microbiology | Microbial Sensitivity Tests | Endocarditis - microbiology | Endocarditis - diagnosis | Prosthesis-Related Infections - microbiology | Endocarditis - mortality | Endocarditis, Bacterial - microbiology | Mycoses - therapy | Adult | Prosthesis-Related Infections - diagnosis | Staphylococcal Infections - microbiology | Heart Failure - etiology | Streptococcal Infections - microbiology | Echocardiography | Endocarditis - therapy | Risk Factors | Heart Valve Prosthesis - adverse effects | Anti-Infective Agents - therapeutic use | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Combined Modality Therapy | Endocarditis, Bacterial - complications | Prosthesis-Related Infections - therapy | Central Nervous System Diseases - etiology | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Mycoses - diagnosis | Endocarditis, Bacterial - therapy | Endocarditis, Bacterial | Analysis | Heart | Bacteria | Infections | Microbiology | Medical diagnosis | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights